Sarah B. Shugarts, Ph.D. - Publications
Affiliations: | 2010 | Pharmaceutical Sciences and Pharmacogenomics | University of California, San Francisco, San Francisco, CA |
Area:
PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Bekker P, Dairaghi D, Seitz L, Leleti M, Wang Y, Ertl L, Baumgart T, Shugarts S, Lohr L, Dang T, Miao S, Zeng Y, Fan P, Zhang P, Johnson D, et al. Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study. Plos One. 11: e0164646. PMID 27768695 DOI: 10.1371/journal.pone.0164646 | 0.316 | |||
2013 | Jacquot C, Moayeri M, Kim B, Shugarts S, Lynch KL, Leavitt AD. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report. Transfusion. 53: 2715-21. PMID 23451879 DOI: 10.1111/Trf.12138 | 0.411 | |||
2009 | Shugarts S, Benet LZ. The role of transporters in the pharmacokinetics of orally administered drugs. Pharmaceutical Research. 26: 2039-54. PMID 19568696 DOI: 10.1007/S11095-009-9924-0 | 0.558 | |||
Show low-probability matches. |